Heidi Fields
Director at Phathom Pharmaceuticals, Inc. (PHAT)
Heidi Fields has filed 17 insider reports with the SEC since March 2021, as director at Phathom Pharmaceuticals, Inc. (PHAT), director at Agilent Technologies, Inc. (A) and insider at Icosavax, Inc. (ICVX). Heidi Fields made no open-market purchases or sales in the last 12 months. The latest filing, on May 21, 2026, reports grant or award at Phathom Pharmaceuticals, Inc. (PHAT).
- Filings
- 17
- Companies
- 3
- Bought on market
- None
- Sold on market
- $806K
Companies where Heidi Fields is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 54,122 | $5.88 | May 21, 2026 | ||||
| Director | $806K | $172.92 | Mar 18, 2025 | ||||
| Insider | 0 | Feb 21, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- May 19, 2026PHATDirector Fields Heidi was granted 24,122 shares, increasing direct ownership by 80% to 54,122 unitsForm 4Grant or award
- Jun 3, 2025PHATDirector Fields Heidi was granted 10,500 shares, increasing direct ownership by 54% to 30,000 unitsForm 4Grant or award
- Mar 14, 2025ADirector Fields Heidi was granted 1,819 sharesForm 4Grant or award
- May 23, 2024PHATFields Heidi was granted 10,500 shares, increasing direct ownership by 117% to 19,500 unitsForm 4Grant or award
- Mar 15, 2024AFields Heidi was granted 1,678 sharesForm 4Grant or award
- Mar 5, 2024-$239KAFields Heidi sold $239,316 worth of shares (1,658 units at $144.34)Form 4Open-market sale
- Mar 5, 2024~$239KAHeidi Fields plans to sell 1,658 shares (~$239K)Form 144Planned sale
- Feb 19, 2024ICVXFields Heidi returned 2,917 shares to the company, closing all direct ownership in the companyForm 4Sale back to the companyTender of shares in a change of control
- Jun 6, 2023ICVXSEC Form 4 filed by Fields HeidiForm 4Grant or award
- May 25, 2023PHATSEC Form 4 filed by Fields HeidiForm 4Grant or award
- Mar 16, 2023ASEC Form 4 filed by Fields HeidiForm 4Grant or award
- Nov 23, 2022-$566KASEC Form 4: Fields Heidi sold $566,482 worth of shares (3,635 units at $155.84)Form 4Open-market sale
- Jun 10, 2022ICVXSEC Form 4: Fields Heidi was granted 5,543 shares, increasing direct ownership by 63% to 14,293 unitsForm 4Grant or award
- May 25, 2022PHATSEC Form 4 filed by Fields HeidiForm 4Grant or award
- Mar 17, 2022ASEC Form 4: Fields Heidi was granted 1,785 sharesForm 4Grant or award
- May 21, 2021PHATSEC Form 4 filed by FIELDS HEIDIForm 4Grant or award
- Mar 18, 2021ASEC Form 4: Heidi Fields was granted 1,850 units of Common StockForm 4Grant or award
Compare Heidi Fields with
- Heidi Fields vs Glenn S Boehnlein1 shared
- Heidi Fields vs Mikael Dolsten1 shared
- Heidi Fields vs Robert Charles Breedlove1 shared
- Heidi Fields vs Jonah Prevost Kirkwood1 shared
- Heidi Fields vs Padraig Mcdonnell1 shared
- Heidi Fields vs Asit Parikh1 shared
Other insiders at the same companies
- Glenn S BoehnleinA
- Mikael DolstenA
- Robert Charles BreedlovePHAT
- Jonah Prevost KirkwoodA
- Timothy Charles DownsA
- Padraig McdonnellA
- Asit ParikhPHAT
- James N TopperPHAT
- Mark StenhousePHAT
- Frank KarbePHAT
- Michael F ColaPHAT
- Theodore R SchroederPHAT
- Michael Steven BucknerA
- Simon MayA
- Meghan HensonA
- Sue H. RatajA
Questions about Heidi Fields
- What is Heidi Fields's role at Phathom Pharmaceuticals, Inc.?
- Heidi Fields reports to the SEC as director at Phathom Pharmaceuticals, Inc. (PHAT), according to the latest filing on May 21, 2026. Heidi Fields has also filed as director at Agilent Technologies, Inc. (A) and insider at Icosavax, Inc. (ICVX).
- How many shares does Heidi Fields own?
- After the latest filing that states it, Heidi Fields directly owned 54,122 shares of Phathom Pharmaceuticals, Inc. (PHAT). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Heidi Fields bought or sold stock recently?
- The most recent open-market sale was on March 5, 2024: sold 1,658 shares of Agilent Technologies, Inc. (A) for $239K at an average of $144.34.
- How do I get alerts when Heidi Fields files?
- Follow Heidi Fields on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Heidi Fields (SEC CIK 0001014330). Totals count each trade once, skipping amendments whose original is on file, from Mar 22, 2021 on. View on SEC EDGAR